Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a study in JAMA Dermatology, dupilumab maintained clinical effectiveness out to 5 years for many patients with ...
Dupixent (dupilumab) is a prescription drug that’s used to treat certain inflammatory conditions, such as atopic dermatitis (a type of eczema). Dupixent comes in a prefilled syringe or prefilled ...
Sanofi SNY and Regeneron’s REGN Dupixent (dupilumab), an injectable monoclonal ... including relapsed/refractory classic Hodgkin’s lymphoma (cHL), cutaneous T-cell lymphoma and NK-cell ...
Accordingly, Dupixent, also called dupilumab, will be indicated in the ... Global Healthcare Conference (Transcript) Regeneron lymphoma antibody drug endorsed for conditional approval in EU ...